This study aimed to evaluate the functional and clinical characteristics of SLC26A3 in CRC while investigating the specific mechanism by which SLC26A3 regulates IκB resulting in NF-κB/p65 nuclear translocation mediated by NHERF2. The gene discussed is NHERF2; the disease is colorectal carcinoma.